Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation

Sponsor
Aydin Adnan Menderes University (Other)
Overall Status
Completed
CT.gov ID
NCT05941195
Collaborator
(none)
45
1
2
5.9
7.6

Study Details

Study Description

Brief Summary

This study, which was planned to examine the effects of cognitive behavioral approach-based psychoeducation on addiction profiles, self-efficacy levels and addiction courses in patients with substance use disorders, was carried out as a randomized controlled experimental study.

Condition or Disease Intervention/Treatment Phase
  • Other: Psychoeducation
N/A

Detailed Description

It can be said that alcohol/substance nurses, by applying cognitive behavioral approach-based psychoeducation to patients with substance use disorders, can have a positive effect on reducing the severity of addiction, increasing their self-efficacy levels, and providing the care, education and counseling support that patients need.

The aim of this study is to examine the effects of cognitive behavioral approach-based psychoeducation applied to patients with substance use disorder on addiction profiles, self-efficacy levels and addiction courses.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Following recruitment, person who the substance use disorder were divided into a study and a control group by randomization (1:1 randomization)Following recruitment, person who the substance use disorder were divided into a study and a control group by randomization (1:1 randomization)
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation on Addiction Profile, Self-efficacy and Addiction Course in Substance Use Disorder Randomized Controlled Experimental Study
Actual Study Start Date :
Dec 1, 2022
Actual Primary Completion Date :
Feb 28, 2023
Actual Study Completion Date :
May 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: psychoeducation applied experimental group

The patients in the experimental group received a total of 5 weeks (9 sessions) of cognitive-behavioral-based psychoeducation, consisting of 45-60 minutes, 2 sessions per week and the first session preparation session. In the sessions, the topics determined by using learning activities such as lecture, discussion, summarization, role-play, question/answer and exercises were explained and discussed. At the end of each session, homework was given to facilitate the patient's cognitive and behavioral change between sessions.

Other: Psychoeducation
In the cognitive behavioral approach based psychoeducation given to the experimental group patients; "Addiction and Its Effects", "Increasing and Maintaining Motivation", "The Cognitive Model and the Cognitive Model of Addiction", "Automatic Thoughts That Increase Impulse to Substance Use", "Dysfunctional Beliefs Regarding Substance Use", "High Risk Situations and Coping Skills", " The topics of "Prevention of Slippage and Recurrence" and "Problem Solving" are included.

No Intervention: non-intervention control group

Control group: The control group continued to receive the routine care.

Outcome Measures

Primary Outcome Measures

  1. Addiction Profile Index (Bapi) Clinical Form [The first measurement was made in the 1st week.]

    Addiction Profile Index Clinical Form was created by adding 21 questions to the Addiction Profile Index developed in 2012 to measure the severity of addiction. It consists of 58 questions in total and has 11 sub-dimensions. It evaluates different dimensions of addictions of alcohol and substance users. Two of the six domains of the scale measure mental state, while the others measure some personal characteristics related to addiction .

  2. Addiction Profile Index (Bapi) Clinical Form [The last measurement was made at the 5th week.]

    Addiction Profile Index Clinical Form was created by adding 21 questions to the Addiction Profile Index developed in 2012 to measure the severity of addiction. It consists of 58 questions in total and has 11 sub-dimensions. It evaluates different dimensions of addictions of alcohol and substance users. Two of the six domains of the scale measure mental state, while the others measure some personal characteristics related to addiction.

  3. Addiction Outcome Assessment Index (AOAI) [The first measurement was made in the 1st week.]

    The Addiction Outcome Index (BASI) was developed to measure the treatment course and recovery level of addiction in all areas and to be used in follow-up. The score that can be obtained from the scale is between 0-32. A decrease of 3.5 points from the total score of the scale in clinical follow-up indicates a reliable change .

  4. Addiction Outcome Assessment Index (AOAI) [The last measurement was made at the 5th week.]

    The Addiction Outcome Index (BASI) was developed to measure the treatment course and recovery level of addiction in all areas and to be used in follow-up. The score that can be obtained from the scale is between 0-32. A decrease of 3.5 points from the total score of the scale in clinical follow-up indicates a reliable change .

  5. Self-Efficacy Scale (SES) [The first measurement was made in the 1st week.]

    The scale was first developed in the English language in 1982. It was adapted into Turkish in 1999 and follows the course of self-efficacy expectations that need to be changed in individual therapy during the therapy process. The Self-Efficacy Scale consists of 23 items and 4 sub-factors. A minimum of 23 and a maximum of 115 points can be obtained from the scale. A high total score from the scale indicates that the individual's self-efficacy perception is at a good level.

  6. Self-Efficacy Scale (SES) [The last measurement was made at the 5th week.]

    The scale was first developed in the English language in 1982 . It was adapted into Turkish in 1999 and follows the course of self-efficacy expectations that need to be changed in individual therapy during the therapy process. The Self-Efficacy Scale consists of 23 items and 4 sub-factors. A minimum of 23 and a maximum of 115 points can be obtained from the scale. A high total score from the scale indicates that the individual's self-efficacy perception is at a good level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. To be diagnosed with "Substance Use Disorder" according to The Diagnostic and Statistical Manual of Mental Disorders-V,

  2. To be over 18 years old,

  3. Volunteering to participate in the research.

Exclusion Criteria:
  1. Other than Substance Use Disorder, chronic, requiring ongoing help and care the presence of a medical illness,

  2. Being illiterate (the types of scales to be used must be self-report forms) because of).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aydın Adnan Menderes University Faculy of Nursing, Division Mental HealthNursing Aydın Turkey

Sponsors and Collaborators

  • Aydin Adnan Menderes University

Investigators

  • Principal Investigator: Fatma DEMİRKIRAN, Phd, Aydin Adnan Menderes University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cihan Kocairi, Research Assistant, Aydin Adnan Menderes University
ClinicalTrials.gov Identifier:
NCT05941195
Other Study ID Numbers:
  • Adnan MU
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cihan Kocairi, Research Assistant, Aydin Adnan Menderes University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023